Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

China Anti-heart Failure Drug Market Report to 2021

  • QYR777619
  • 109 Pages
  • November 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Anti-heart Failure Drug

Revenue, means the sales value of Anti-heart Failure Drug

This report studies sales (consumption) of Anti-heart Failure Drug in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Novartis

Pfizer, Inc.

Roche

Sanofi

Merck & Co., Inc.

GlaxoSmithKline plc

Johnson & Johnson

AstraZeneca plc.

Eli Lilly and Company

Abbvie

AMGen

Teva Pharmaceutical Industries Ltd.

Bayer AG

Bristol-Myers Squibb

Astellas Pharma

Daiichi Sankyo

Abbott Laboratories

Yangtze River Pharmaceutical Group

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Cardiac Glycosides

Phosphodiesterase Inhibitors

Type III

Split by applications, this report focuses on sales, market share and growth rate of Anti-heart Failure Drug in each application, can be divided into

First Level Hospital

Two Level Hospital

Three Level Hospital

Others

Table of Contents

China Anti-heart Failure Drug Market Report 2021

1 Anti-heart Failure Drug Overview

1.1 Product Overview and Scope of Anti-heart Failure Drug

1.2 Classification of Anti-heart Failure Drug

1.2.1 Cardiac Glycosides

1.2.2 Phosphodiesterase Inhibitors

1.2.3 Type III

1.3 Applications of Anti-heart Failure Drug

1.3.1 First Level Hospital

1.3.2 Two Level Hospital

1.3.3 Three Level Hospital

1.3.4 Others

1.4 China Market Size (Value and Volume) of Anti-heart Failure Drug (2011-2021)

1.4.1 China Anti-heart Failure Drug Sales, Revenue and Price (2011-2021)

1.4.2 China Anti-heart Failure Drug Sales and Growth Rate (2011-2021)

1.4.3 China Anti-heart Failure Drug Revenue and Growth Rate (2011-2021)

2 China Anti-heart Failure Drug Competition by Manufacturers

2.1 China Anti-heart Failure Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 China Anti-heart Failure Drug Revenue and Share by Manufactures (2015 and 2016)

3 China Anti-heart Failure Drug (Volume and Value) by Type

3.1 China Anti-heart Failure Drug Sales and Market Share by Type (2011-2021)

3.2 China Anti-heart Failure Drug Revenue and Market Share by Type (2011-2021)

4 China Anti-heart Failure Drug (Volume) by Application

5 China Anti-heart Failure Drug Manufacturers Analysis

5.1 Novartis

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Anti-heart Failure Drug Product Type and Technology

5.1.2.1 Cardiac Glycosides

5.1.2.2 Phosphodiesterase Inhibitors

5.1.3 Anti-heart Failure Drug Sales, Revenue, Price of Novartis (2015 and 2016)

5.2 Pfizer, Inc.

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharmaceuticals Product Type and Technology

5.2.2.1 Cardiac Glycosides

5.2.2.2 Phosphodiesterase Inhibitors

5.2.3 Pharmaceuticals Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)

5.3 Roche

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Roche Product Type and Technology

5.3.2.1 Cardiac Glycosides

5.3.2.2 Phosphodiesterase Inhibitors

5.3.3 Roche Sales, Revenue, Price of Roche (2015 and 2016)

5.4 Sanofi

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Eli Lilly and Company Product Type and Technology

5.4.2.1 Cardiac Glycosides

5.4.2.2 Phosphodiesterase Inhibitors

5.4.3 Sanofi Sales, Revenue, Price of Sanofi (2015 and 2016)

5.5 Merck & Co., Inc.

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Merck & Co., Inc. Product Type and Technology

5.5.2.1 Cardiac Glycosides

5.5.2.2 Phosphodiesterase Inhibitors

5.5.3 Merck & Co., Inc. Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)

5.6 GlaxoSmithKline plc

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 GlaxoSmithKline plc Product Type and Technology

5.6.2.1 Cardiac Glycosides

5.6.2.2 Phosphodiesterase Inhibitors

5.6.3 GlaxoSmithKline plc Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)

5.7 Johnson & Johnson

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Johnson & Johnson Product Type and Technology

5.7.2.1 Cardiac Glycosides

5.7.2.2 Phosphodiesterase Inhibitors

5.7.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

5.8 AstraZeneca plc.

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 AstraZeneca plc. Product Type and Technology

5.8.2.1 Cardiac Glycosides

5.8.2.2 Phosphodiesterase Inhibitors

5.8.3 AstraZeneca plc. Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)

5.9 Eli Lilly and Company

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Eli Lilly and Company Product Type and Technology

5.9.2.1 Cardiac Glycosides

5.9.2.2 Phosphodiesterase Inhibitors

5.9.3 Eli Lilly and Company Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)

5.10 Abbvie

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Abbvie Product Type and Technology

5.10.2.1 Cardiac Glycosides

5.10.2.2 Phosphodiesterase Inhibitors

5.10.3 Abbvie Sales, Revenue, Price of Abbvie (2015 and 2016)

5.11 AMGen

5.12 Teva Pharmaceutical Industries Ltd.

5.13 Bayer AG

5.14 Bristol-Myers Squibb

5.15 Astellas Pharma

5.16 Daiichi Sankyo

5.17 Abbott Laboratories

5.18 Yangtze River Pharmaceutical Group

6 Anti-heart Failure Drug Technology and Development Trend

6.1 Anti-heart Failure Drug Technology Analysis

6.2 Anti-heart Failure Drug Technology Development Trend

7 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Anti-heart Failure Drug

Table Classification of Anti-heart Failure Drug

Figure China Sales Market Share of Anti-heart Failure Drug by Type in 2015

Figure Cardiac Glycosides Picture

Figure Phosphodiesterase Inhibitors Picture

Table Applications of Anti-heart Failure Drug

Figure China Sales Market Share of Anti-heart Failure Drug by Application in 2015

Figure First Level Hospital Examples

Figure Two Level Hospital Examples

Figure Three Level Hospital Examples

Figure Others Examples

Table China Anti-heart Failure Drug Sales, Revenue and Price (2011-2021)

Figure China Anti-heart Failure Drug Sales and Growth Rate (2011-2021)

Figure China Anti-heart Failure Drug Revenue and Growth Rate (2011-2021)

Table China Anti-heart Failure Drug Sales of Key Manufacturers (2015 and 2016)

Table China Anti-heart Failure Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Anti-heart Failure Drug Sales Share by Manufacturers

Figure 2016 Anti-heart Failure Drug Sales Share by Manufacturers

Table China Anti-heart Failure Drug Revenue by Manufacturers (2015 and 2016)

Table China Anti-heart Failure Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China Anti-heart Failure Drug Revenue Share by Manufacturers

Table 2016 China Anti-heart Failure Drug Revenue Share by Manufacturers

Table China Anti-heart Failure Drug Sales and Market Share by Type (2011-2021)

Table China Anti-heart Failure Drug Sales Share by Type (2011-2021)

Figure Sales Market Share of Anti-heart Failure Drug by Type (2011-2021)

Figure China Anti-heart Failure Drug Sales Growth Rate by Type (2011-2021)

Table China Anti-heart Failure Drug Revenue and Market Share by Type (2011-2021)

Table China Anti-heart Failure Drug Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Anti-heart Failure Drug by Type (2011-2021)

Figure China Anti-heart Failure Drug Revenue Growth Rate by Type (2011-2021)

Table China Anti-heart Failure Drug Sales and Market Share by Application (2011-2021)

Table China Anti-heart Failure Drug Sales Share by Application (2011-2021)

Figure Sales Market Share of Anti-heart Failure Drug by Application (2011-2021)

Figure China Anti-heart Failure Drug Sales Growth Rate by Application (2011-2021)

Table Novartis Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Novartis (2015 and 2016)

Table Pfizer, Inc. Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)

Table Roche Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Roche (2015 and 2016)

Table Sanofi Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Sanofi (2015 and 2016)

Table Merck & Co., Inc. Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)

Table GlaxoSmithKline plc Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

Table AstraZeneca plc. Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)

Table Eli Lilly and Company Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)

Table Abbvie Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Abbvie (2015 and 2016)

Table AMGen Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of AMGen (2015 and 2016)

Table Teva Pharmaceutical Industries Ltd. Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)

Table Bayer AG Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Bayer AG (2015 and 2016)

Table Bristol-Myers Squibb Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)

Table Astellas Pharma Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Astellas Pharma (2015 and 2016)

Table Daiichi Sankyo Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)

Table Abbott Laboratories Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Abbott Laboratories (2015 and 2016)

Table Yangtze River Pharmaceutical Group Basic Information List

Table Anti-heart Failure Drug Sales, Revenue, Price of Yangtze River Pharmaceutical Group (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370